BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weitz IC. Thrombotic microangiopathy in cancer. Thromb Res 2018;164 Suppl 1:S103-5. [PMID: 29703465 DOI: 10.1016/j.thromres.2018.01.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 García-Carro C, Draibe J, Soler MJ. Onconephrology: Update in Anticancer Drug-Related Nephrotoxicity. Nephron 2022;:1-13. [PMID: 35717937 DOI: 10.1159/000525029] [Reference Citation Analysis]
2 Liu WB, Ma JX, Tong HX. Successful treatment in one myelodysplastic syndrome patient with primary thrombocytopenia and secondary deep vein thrombosis: A case report . World J Clin Cases 2022; 10(14): 4640-4647 [DOI: 10.12998/wjcc.v10.i14.4640] [Reference Citation Analysis]
3 Daily ZH, Rizvi SS, Baez-bonilla R. Atypical Hemolytic Uremic Syndrome in a Patient With Metastatic Peritoneal Serous Carcinoma: A Case Report. Cureus 2022. [DOI: 10.7759/cureus.22624] [Reference Citation Analysis]
4 唐 文. Advances in Research on VEGF Pathway Inhibitors Related Renal Injury. ACM 2022;12:7462-7472. [DOI: 10.12677/acm.2022.1281077] [Reference Citation Analysis]
5 Cervantes CE, Kant S, Atta MG. The Link Between Conventional and Novel Anti-Cancer Therapeutics with Thrombotic Microangiopathy. Drug Metab Lett 2021;14:97-105. [PMID: 34279209 DOI: 10.2174/1872312814666210716141633] [Reference Citation Analysis]
6 Tu KH, Fan PY, Chen TD, Chuang WY, Wu CY, Ku CL, Tian YC, Yang CW, Fang JT, Yang HY. TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities. Int J Mol Sci 2021;22:6286. [PMID: 34208103 DOI: 10.3390/ijms22126286] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Sharma S, Pavuluri S, Srinivasan K, Ghouse M. Thrombotic Microangiopathy in a Patient With COVID-19 Infection and Metastatic Cholangiocarcinoma. J Hematol 2021;10:83-8. [PMID: 34007371 DOI: 10.14740/jh825] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Eby C. Bleeding Associated with Disseminated Intravascular Coagulation. Management of Bleeding Patients 2021. [DOI: 10.1007/978-3-030-56338-7_17] [Reference Citation Analysis]
9 Shatzel JJ, Deloughery TG. Thrombotic Microangiopathies. Blood and Marrow Transplant Handbook 2021. [DOI: 10.1007/978-3-030-53626-8_38] [Reference Citation Analysis]
10 Piedrafita A, Ribes D, Cointault O, Chauveau D, Faguer S, Huart A. Plasma exchange and thrombotic microangiopathies: From pathophysiology to clinical practice. Transfus Apher Sci 2020;59:102990. [PMID: 33272850 DOI: 10.1016/j.transci.2020.102990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
11 Rosner MH, Jhaveri KD, McMahon BA, Perazella MA. Onconephrology: The intersections between the kidney and cancer. CA Cancer J Clin 2021;71:47-77. [PMID: 32853404 DOI: 10.3322/caac.21636] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
12 Castelli R, Bergamaschini L, Teatini T, Cilumbriello L, Schiavon R, Gallipoli P, Deliliers GL. Does Outcome/Survival of Patients With Myelodysplastic Syndromes Should Be Predicted by Reduced Levels of ADAMTS-13? Results From a Pilot Study. Clin Lymphoma Myeloma Leuk 2020;20:e461-7. [PMID: 32507387 DOI: 10.1016/j.clml.2019.12.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Jacobs E, Ortiz C, Licht C. The Role of Complement in the Pathogenesis of HUS and the TMA Spectrum Disorders. Curr Pediatr Rep 2019;7:1-11. [DOI: 10.1007/s40124-019-00186-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]